bg-img9.jpg
8.jpg
Factors Affecting Participation Rates in Population-Based Biobanking

A systematic review and meta-analysis of baseline participation rates and their determinants performed by van Zon et al. (2016) found that recruitment methods and design affect participation rates.1 Population-based biobanks are essential platforms for innovation and knowledge generation in health care research, specifically in regards to how we prevent, treat and cure widespread diseases. Therefore, willingness to participate from the population is pivotal if biobank studies are to continue to contribute to public health research.

Topic: Biobanking and Biorepository, Topic: Public..........

The Evolution of Public Health Research: HIV/AIDS

No one reading this blog was alive when John Snow created his famed cholera map of Soho, or when Robert Koch discovered M. tuberculosis. Many of us weren’t alive, much less paying attention to scientific studies, when the Framingham Heart Study was published to link cigarettes to lung cancer. But there’s one epidemic that everyone should be familiar with. One that was extensively covered in the media, that aspiring children dreamed of curing, that has inspired so many award-winning movies, that was declared a threat to national security.

Topic: Public Health Research, The Evolution of Pu..........

How to Maintain Sample Integrity During Sample Transfer

The data that lies within your biospecimen collections holds the keys to your research and, as we’ve discussed previously, it’s imperative to maintain proper temperature to ensure sample integrity.  This is a challenge ordinarily, but even more so when attempting to transfer samples.

Topic: Biobanking and Biorepository, Topic: Public..........

Gut Bacteria Rivals Immunotherapies in Cancer Treatment

The human gut contains more than 100 trillion bacteria from perhaps 500 or more different species. In fact, gut bacteria outnumber the cells in the human body. The vast number of these bacteria has caused researchers to take a closer look at how they are related to health and disease. Now, breaking scientific research suggests that gut bacteria may be more important than anyone previously realized: they appear to be effective cancer treatments.

Topic: Laboratory Processing, Topic: Cell Therapy ..........

The Importance of Early Planning for Clinical Supplies: Part II

In Part I of this blog series, I identified some of the challenges in supporting clinical trials and a few reasons why early planning for clinical supplies is very important. In Part II, let’s look at three areas of clinical supply support that can greatly benefit from having the support team involved from the start and given ample time to design and contribute to the protocol:

Topic: Cold-Chain Logistics, Topic: Clinical Trial..........

The Link Between Epigenetics and CRISPR-Cas9

When it was first released in 2012, the CRISPR-Cas system stunned scientists with its potential for revolutionizing biological research. Researchers initially noticed that bacterial genomes often contain “clustered regularly interspaced short palindromic repeats,” now dubbed CRISPR sequences. When scientists provide the Cas enzyme with a guide RNA sequence, they can tell it precisely where to slice the DNA. This allows unprecedented control over DNA slicing and insertion of new genetic code.

Topic: Laboratory Processing, Topic: Cell Therapy ..........

Safeguarding Data Across Biotech Global Boundaries

In an era of “big data,” companies across all industries are collecting consumer information to provide effective solutions to problems or better market their products. Industry watchdog groups have long been concerned about the implications of data collection on consumer privacy. These issues become even more complex when conducting transactions across international borders. A recently drafted European Union-United States Privacy Shield agreement is intended to clarify the privacy principles U.S. organizations must meet to comply with EU privacy laws.

Topic: Biobanking and Biorepository, Content: Blog

The Importance of Early Planning for Clinical Supplies: Part I

Beating other investors to an offer or getting ample time to support a clinical trial can yield big benefits and returns. The advantages from the financial perspective can be fairly evident but the gains from having plenty of time to plan, design and implement support functions for clinical supplies may not be so obvious. In this two part blog series, I will discuss the challenge of supporting clinical trials and the importance of early planning for clinical supplies.

Topic: Cold-Chain Logistics, Topic: Clinical Trial..........

Increasing Global Cell Therapy Awareness: ISCT 2016

We are pleased to announce our participation as a platinum sponsor at next week's International Society for Cellular Therapy (ISCT) 22nd Annual Meeting in Singapore. This will be the first time that the ISCT Annual Meeting will be held in Asia and is a reflection of the increasing global awareness of the importance of Asia in the field of Cellular Therapies. With over 1000 international delegates registered to attend, ISCT 2016 is a great opportunity to network with experts within the global cell therapy arena. We are honored to showcase our global integrated solution for cell therapy clinical and commercial development in conjunction with our parent company, Thermo Fisher Scientific.

Topic: Cell Therapy Solutions, Content: Blog

The Microbiome of the Skin and Beyond: The MoBE

Our skin is not only our largest organ, and the surface through which we experience the world, it is also a complex ecosystem in its own right. Grice et al (2008)1 estimated that more than a million micro-organisms of more than a hundred distinct species reside on a square centimeter of skin. The recent research into the microbiome of the skin shows that we have not only a great diversity of microorganisms in our skin microbiome, but also a high degree of variation from individual to individual. And although research into the interactions between the skin microbiome and dermal and other disorders is fairly new, it has become clear that the more diverse the microbiome, the healthier the skin.

Topic: Biobanking and Biorepository, Topic: Labora..........

Amazing Samples: Buccal Up for Some Cheeky Research

Most researchers know about buccal cells  the easily sloughed-off cells from the inside of the cheek. The collection of these cells is relatively non-invasive, which gives it many of the same advantages as spit and mucus that we’ve already discussed. Because of this, many studies, including some in social science, utilize buccal swabs to increase the amount of data they’re collecting.

However, even if it’s popular, don’t let that diminish its value. From biomarker studies to stem cell research, buccal cells have proven time and time again to be a hugely useful source of biological data. Last time in our Amazing Samples blog series, we scratched the surface of research with skin cells. This time, buccal up and get ready for a cheekier kind of Amazing Sample!

Topic: Biobanking and Biorepository, Topic: Cell T..........

World Stem Cells & Regenerative Medicine Congress


We are pleased to announce our participation at the 11th Annual World Stem Cells & Regenerative Medicine Congress on May 18-20 in London, England. In the past, this event focused on developments in stem cell therapies and innovations within regenerative medicine. As the industry progresses, this year's conference will focus on the cell therapies that have made it to market, the innovations of academia and universities, and the use of stem cells for drug discovery. Additionally, this year's event will be co-located with World Precision Medicine Congress and the Cord Blood World Europe.

Topic: Biobanking and Biorepository, Topic: Cell T..........